RLI Corp. (RLI) reported earnings 30 days ago. What's next for the stock?

RLI's strong underwriting, casualty growth and rising investment income support returns, but catastrophe risks and competition pose challenges.

RLI's decentralized underwriting model drives sustained profitability, with disciplined risk selection supporting strong margins and shareholder returns.

PEORIA, Ill.--(BUSINESS WIRE)-- #casualtyinsurance--RLI announces Q3 regular cash dividend of $0.18 per share, payable on September 15, 2026, to shareholders of record as of August 31, 2026.

Arrowstreet Capital Limited Partnership raised its stake in RLI Corp. (NYSE: RLI) by 6.9% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 520,422 shares of the insurance provider's stock after acquiring an additional 33,547 shares during the

Dimensional Fund Advisors LP boosted its holdings in RLI Corp. (NYSE: RLI) by 1.1% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,920,823 shares of the insurance provider's stock after buying an additional 21,299 shares during the quarter. Dimensional Fund Advisors

RLI's Q2 results benefit from premium growth, higher investment income and favorable reserve development, lifting earnings above estimates.

RLI NYSE: RLI reported another quarter of profitable underwriting and higher investment income, with management emphasizing disciplined growth, capital returns and selectivity in increasingly competitive specialty insurance markets.

RLI Corp. (RLI) Q2 2026 Earnings Call Transcript

The Ariel Small/Mid Cap Value Composite rose +15.08% gross of fees (+14.95% net of fees) in the quarter, falling short of both the Russell 2500 Value Index's +18.50% return and the +20.26% gain posted by the Russell 2500 Index. Live entertainment, media, and technology company, Sphere Entertainment Co. was the top contributor during the quarter on solid earnings and improving operating fundamentals. Shares of Prestige Consumer Healthcare moved lower following disappointing earnings, driven primarily by ongoing supply constraints in its eye care segment and extended lead times in the Middle East.